Management of Acne Vulgaris with Topical Medicine: Current Perspective
Role of Biotechnology in Tuberculosis control in India – A Revolution in diagnostics sector
Use of technology can minimize the need for agriculture loan waivers, making them redundant eventually
CSIR committed to make common man’s life easy: Dr Shekhar C Mande, DG CSIR
Shreeji Biotech : Approaching Multidimensionally from the starting
# Coming Soon: New generation of plant-based ‘green crackers’ for less-polluting Diwali
# New evidence released on the trends of Non-Communicable diseases and Suicide for every state of India by ICMR
# Illumina Acquires Pacific Biosciences for $1.2 Billion
# Six professors win Infosys Prize 2018 for science and research
# The DBT/Wellcome Trust India Alliance Celebrates 10 Years of Enabling Biomedical Research in India
# Appendix identified as a potential starting point for Parkinson’s disease
# Cellphone technology developed to detect HIV
# Evidence of restored vision in rats following cell transplant
# First assessment of planetary boundaries for antibiotic and pesticide resistance
# Just a single missing gene may lead to miscarriage
# Scientists made functioning 3D human neural networks from stem cells
# Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research
#BRSI – IICT BIOSD 2018, 22-25 November, Hyderabad, India
#BEHSD 2018, 27-28 November , CSIR-IITR Lucknow, India
#NGS in Clinical Genomics, 29-30 November, Bangalore, India
#BEST 2019, January, Chennai
#6thAIST International Imaging workshop, 20-27 January 2019, Japan.
News & Articles
October 2018 | Free Access
Prof B K Thelma, known as Thelma among the BioScience community is a well recognized leader in Medical Genomics Scientific research and among the few scientists who translated her research into application. Dr
Thelma is an excellent example to understand how Genomics is done and how it is applied for the welfare of general public. Thus we are trying to write as much as possible about her for our readers who search for new avenues and career prospects in Genomics.
October 2018 | According to Goldstein Research analyst forecast the genomics market size is set to reach USD 24.5 billion by 2025, at a CAGR of 11.2%. Grand View Research, Inc. estimates the global genomics market size will reach USD 27.6 billion by 2025. MarketsandMarkets Research Private Ltd. valued global Genomics market at USD 13.45 Billion in 2016 and is expected to grow at a CAGR of 10.2% to reach to USD 23.88 Billion by 2022. Research and Markets’ report The global Genomics market is expected to reach USD 23.88 Billion by 2022 from USD 14.71 Billion in 2017, at a CAGR of 10.2%.
October 2018 | As said ‘‘an ace in the hole for DNA sequencing’’ by world’s most reputed Science journal i.e. ”Nature”, it is true that Oxford Nanopre is going to change what people think of Genomics. It is also evident that Gordon Sanghera and his team have developed a revolutionary device that will change the course of what people know and do with DNA Sequencing. So this special article will show you that why OXFORD has been selected for special coverage despite the presence of other major players in the market.
October 2018 | The reason why Genotypic Technology came 1st in our survey is because no other company is providing these many Genomics services to clientele from a such long time. Unlike others ‘GT’ company is both into R&D and sales of Genomics Services and products.
June 2018 | Dr Poonam Sharma studied at Jawahar Lal Nehru University, New Delhi and successfully obtained her M. Phil. and Ph.D. from there in 2000. She has published over a dozen of research papers and review articles in several referred and reputed national and international journals. She has attended several national and international conferences/seminars related to her area of academic research interests. She has already published eight books while another two are in the press. She is the Founder and Director of Gyan Bindu Academy Pvt. Ltd., a 2005 start up which has grown by leaps and bounds over the past few years into India’s top Life Sciences/Biosciences study assistance services provider
June 2018 | The department of Biotechnology in India was started in year 1986 and born out a new era of development in the country but before a decade ago the seed was sown when Ministry of Education’s most pioneering effort was instrumental in the creation of Biochemical Engineering Research Centre at IIT Delhi with substantial assistance from the Swiss Federal Institute of Technology, Zurich, Switzerland to make available state-of-the-art infrastructure for education, training, and research in biochemical engineering and biotechnology in 1974.
June 2018 | In my own experience, when parents ask questions about biotechnology, I feel they somehow came to know that biotechnology has a huge potential, but they have no idea what biotechnology is! People who really know about the basics and scope of biotechnology, with good counselling skills are few and at this time, experienced faculty, or professionals from industry, and/or individual coaches and coaching institutes can help understand Biotechnology as a career prospect. Amongst, only coaching institutes are easily available to pre-college and college students as a guide for this field. The probable reasons why biotech-coaching institutes are becoming integral to students are discussed:
June 2018 | India has around 60 coachings which provide teaching assistance to more than 10,000 students on 6 month basis. These are available all over India but main hotspots are Delhi, U.P and Chandigarh, slowly they all are developing and giving valuable assistance to young generation. The recent time saw sudden increase in number of coachings from 15-20 in 2013 and now 60 in 2018. This shows that Biotech coaching for MSc and NET is valuable commodity for the biotech market, they help to produce scientific talent in the country like other exams of medical, engineering, UPSC etc.
May 2018 | We arranged a talk with CEO of India’s pioneer biotech company built on stem cell based technologies at Hyderabad, India. She talks about current govt. regulations and business revenue generation of Stem cell industry. Recently govt. has also decided to frame Stem Cell therapy guidelines with high possibility to bring it in the gamut of healthcare industry. The purpose of this talk is to share the experience of leaders of this niche biotech business and to help next generation entrepreneurs understand the nuances to take risks and stay motivated.
May 2018 | More than minimally manipulated and substantially manipulated stem cells’ would be considered as ‘drug’ under the amended Drugs and Cosmetics Rule, 1945, whereas ‘minimally manipulated stem cells’ would form part of the ‘stem cell therapy’ and fall under the purview of surgeons or clinicians as opposed to ‘stem cell drugs’ which would be a product or a drug.
May 2018 | Stemedica has patented method of culturing cells under hypoxic conditions of 3-5% O2, resulting in much higher efficacy, as seen in several ongoing global clinical trials and numerous case reports. The hypoxic Stem Cells are fully characterized (Figure 4) with all major biomarkers identified (no CD34 indicating pure MSC cultures, with no hematopoietic or progenitor cells).
May 2018 | By Ranjani Rajasekaran and J. John Kirubaharan
Genome editing technology evolved steadily with consistent improvisation of the former technology. One such improvised technology was CRISPR-Cas9 which exploited the microbial adaptive immune system – CRISPR – found in bacteria and archaea. It was initially found in the E.coli K12 bacterial genome. Later, in the year 2002, this junk of DNA was named as Clustered Regularly Interspaced Short Palindromic Repeat’ – CRISPR.
May 2018 | Stem cells are cells that have the potential to develop into some or many different cell types in the body, depending on whether they are multipotent or pluripotent. Serving as a sort of repair system, they can theoretically divide without limit to replenish other cells for as long as the person or animal is still alive.
News in Focus
April 2018 | By Biotech Express News Bureau | Government of India and World Bank Sign Agreement to Invest in Technology that Addresses India’s Public Health Priorities. The $125 million loan from the International Bank for Reconstruction and Development (IBRD), has a 5-year grace period, and a maturity of 19 years.